You can buy or sell Viveve and other stocks, options, ETFs, and crypto commission-free!
Viveve Medical, Inc. engages in the provision of health products. Its activities include development and distribution of women's health solutions. Read More Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The company was founded on March 3, 1987 and is headquartered Englewood, CO.
52 Week High
52 Week Low
Seeking AlphaMar 15
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q4 2018 Results - Earnings Call Transcript
Viveve Medical, Inc. (NASDAQ:VIVE) Q4 2018 Earnings Conference Call March 14, 2019 5:00 PM ET Company Participants Scott Durbin - CEO Jeannie Swindle - Senior Director of Corporate Communications Conference Call Participants Josh Jennings - Cowen Matt Wizman - Raymond James Jonathan Block - Stifel Anthony Vendetti - Maxim Group Jeffrey Cohen - Ladenburg Thalmann Suraj Kalia - Northland Securities Matt Hewitt - Craig-Hallum Operator Good afternoon and welcome to the Viveve Fourth Quarter 2018 Fi...
Seeking AlphaMar 11
Viveve completes enrollment in VIVEVE II trial
Viveve Medical (NASDAQ:VIVE) has completed enrollment in its VIVEVE II trial, a randomized, double-blinded study to evaluate the safety and efficacy of its cryogen-cooled monopolar radiofrequency (CMRF) technology for the improvement of sexual function in women following vaginal childbirth.
Stock Price, News, & Analysis for Viveve Medical
Press coverage about VIVE stock has been trending negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Viveve Medical earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 4.0 out of 10, mean...
-$0.35 per share
-$0.38 per share